Monitor for future 424B prospectus supplements or 8-Ks that may announce actual offerings under these shelf registrations, which could lead to near-term dilution given the company's small $7M market cap.
Price Chart
Executive Summary
Can-Fite BioPharma has two shelf registration statements (File Nos. 333-269485 and 333-288890) that became effective on March 31, 2026, allowing the company to issue unspecified amounts of securities from time to time. This creates a potential for future dilution, though no specific offering size or timing is disclosed.
Key Facts
- Two EFFECT filings (Accession Nos. 9999999995-26-001005 and 9999999995-26-001009) from Can-Fite BioPharma became effective on March 31, 2026.
- Each relates to a separate shelf registration statement (333-269485 and 333-288890) under the Securities Act of 1933.
- The filings do not disclose the amount or type of securities to be offered, nor any pricing or timing details.
- Shelf registrations allow companies to issue securities quickly when market conditions are favorable.
Financial Impact
Potential for future dilution; exact magnitude unknown as no offering size is specified.
Risk Factors
- Future issuance under the shelf could significantly dilute existing shareholders.
- Low market cap increases sensitivity to any new share issuance.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (CANF) — Batch item 1 | 9999999995-26-001005 |
| Document: 9999999995-26-001005-index.html | 9999999995-26-001009 |
| Document: 9999999995-26-001005.txt | 9999999995-26-001005 |
| EFFECT Filing (CANF) — Batch item 4 | 9999999995-26-001009 |
| Document: 9999999995-26-001009-index.html | 9999999995-26-001005 |
| Document: 9999999995-26-001009.txt | 9999999995-26-001005 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | $1.95 | awaiting T+5 | — | $1.72 (−11.79%) |
Oct 13, 2026 13d ago | EFFECT | $1.95 $1.89 | ▲ +3.08% | ▲ +1.93% | $1.72 (+11.79%) |
Oct 13, 2026 13d ago | EFFECT | $1.95 $1.89 | ▲ +3.08% | ▲ +1.93% | $1.72 (+11.79%) |
Sep 14, 2026 6w ago | EFFECT | $2.30 $2.22 | ▲ +3.48% | ▲ +3.58% | $1.72 (+25.22%) |
Sep 9, 2026 6w ago | 6-K | $2.19 $2.24 | ▲ +2.28% | ▲ +3.38% | $1.72 (−21.46%) |
Sep 3, 2026 7w ago | 6-K | $2.35 $2.33 | ▼ −0.85% | ▲ +0.30% | $1.72 (−26.81%) |
Sep 2, 2026 7w ago | 6-K | $2.36 $2.16 | ▼ −8.47% | ▼ −7.52% | $1.72 (−27.12%) |
Sep 2, 2026 7w ago | Press Release | $2.36 $2.16 | ▲ +8.47% | ▲ +7.52% | $1.72 (+27.12%) |
Sep 2, 2026 7w ago | 6-K | $2.36 $2.16 | ▼ −8.47% | ▼ −7.52% | $1.72 (−27.12%) |
Aug 17, 2026 10w ago | 6-K | $3.58 $3.35 | ▼ −6.42% | ▼ −5.23% | $1.72 (−51.96%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers